Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Shanghai 10th People's Hospital is the lead sponsor of 30 current clinical trials in our China register. 14 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Infliximab, Adalimumab and Amino acid (15) peritoneal dialysis. The most-studied condition is Hypertension.

ClinicalTrials.gov trials by status

Recruiting1447%
Not yet open1033%
Active, closed413%
By invitation27%

Trials by phase

Observational1447%
Not applicable1447%
Phase 427%

Clinical trials sponsored by Shanghai 10th People's Hospital

30 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Study of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population NCT05311137 · ClinicalTrials.gov ↗ · Atrial Fibrillation	Observational	Recruiting	2022-05	China
Multidisciplinary Diagnosis and Treatment of Polycystic Ovary Syndrome NCT06047574 · ClinicalTrials.gov ↗ · Polycystic Ovary Syndrome	Observational	Recruiting	2023-09	China
Myocardial Infarction and Periodontitis: Periodontal Health Intervention. NCT06745141 · ClinicalTrials.gov ↗ · Acute Myocardial Infarction (AMI), Periodontal Disease	Not applicable	Recruiting	2020-12	China
Integrative Analysis of Human Glioblastoma Multiforme NCT03005132 · ClinicalTrials.gov ↗ · GBM	Observational	Recruiting	2016-01	China
Integrative Analysis of Large-cell Lung Cancer NCT02917369 · ClinicalTrials.gov ↗ · Lung Cancer	Observational	Recruiting	2016-01	China
Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia NCT07662330 · ClinicalTrials.gov ↗ · Obesity & Overweight, Hyperlipidemia Drug: Spermidine	Not applicable	Recruiting	2026-01	China
Treatment of Perioperative Neurocognitive Disorders With Olfactory Enrichment NCT06488807 · ClinicalTrials.gov ↗ · Perioperative Neurocognitive Disorder	Not applicable	Recruiting	2025-04	China
Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure NCT04062500 · ClinicalTrials.gov ↗ · Heart Failure	Observational	Recruiting	2018-01	China
Innate Immune Cell Phenotypes and Early Fibrotic Repair in Acute Myocardial Infarction NCT07764588 · ClinicalTrials.gov ↗ · Myocardial Infarction	Observational	Recruiting	2026-01	China
The Impact of Atrial Pressure Change Before and After Combined Procedure NCT05106270 · ClinicalTrials.gov ↗ · Atrial Fibrillation, Heart Failure	Observational	Recruiting	2021-11	China
A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart Disease NCT06681506 · ClinicalTrials.gov ↗ · Ischemic Heart Disease, Cardiac Rehabilitation	Not applicable	Recruiting	2024-01	China
AI-Empowered Fundus Platform NCT07424755 · ClinicalTrials.gov ↗ · High Myopia	Observational	Recruiting	2024-10	China
BurdEn of NEw Onset Atrial FIbrillation in patienTs With Acute Myocardial Infarction NCT04528511 · ClinicalTrials.gov ↗ · Atrial Fibrillation New Onset, Acute Myocardial Infarction	Observational	Recruiting	2020-10	China
Comparison of the Efficacy of Different Biologic Agents in Preventing Postoperative Endoscopic Recurrence of Crohn's Disease NCT07694674 · ClinicalTrials.gov ↗ · Inflamatory Bowel Disease, Crohn Disease (CD) Drugs: Adalimumab, Infliximab, Ustekinumab	Observational	Recruiting	2026-01	China
A Multicenter Clinical Study on Protein Absorption Efficiency in Patients With Pancreatic Exocrine Insufficiency in the ICU NCT07709611 · ClinicalTrials.gov ↗ · High-risk Patients With Pancreatic Exocrine Insufficiency, Enteral Nutrition Feeding	Phase 4	Not yet open	2026-07	China
Efficacy and Safety of Coenzyme I for Injection on Vascular Aging. NCT07328100 · ClinicalTrials.gov ↗ · Vascular Aging, NAD Drug: Coenzyme I	Not applicable	Not yet open	2026-01	China
Assessment and Digital-health Based Intervention on Subclinical Organ Damage and Cardiovascular Risk in Chinese NCT05435898 · ClinicalTrials.gov ↗ · Cardiovascular Diseases, Cardiovascular Morbidity, Subclinical Organ Damage	Observational	Not yet open	2022-10	China
Efficacy and Safety of Renal Denervation on Isolated Diastolic Hypertension NCT06783296 · ClinicalTrials.gov ↗ · Hypertension, Renal Denervation Therapy	Not applicable	Not yet open	2026-01	China
An Observational, Multicenter Study to Evaluate the Effectiveness of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection NCT07528040 · ClinicalTrials.gov ↗ · Crohn's Disease (CD) Drug: Guselkumab	Observational	Not yet open	2026-04	China
Intervention Study on Digital Health Management NCT06949306 · ClinicalTrials.gov ↗ · Hypertension, Hyperlipidemia	Not applicable	Not yet open	2025-07	China
Noninvasive Assessment of Pulmonary Fluid Levels by Remote Dielectric Sensing Technology to Improve Cardiac InsUfficieney During Ischemia-Reperfusion and Clinical Outcomes in MyocArdiaL Infarction NCT06671067 · ClinicalTrials.gov ↗ · Acute Myocardial Infarction, Acute Decompensated Heart Failure (ADHF)	Not applicable	Not yet open	2024-11	China
Evaluating the Diagnostic Performance and Impact on Clinical Outcomes of the NuRapid-CRISPR Pathogen Profile Assay in ICU Patients With Sepsis NCT07580001 · ClinicalTrials.gov ↗ · Sepsis	Not applicable	Not yet open	2026-07	China
DCB for CAD With Type 2 Diabetes NCT07009938 · ClinicalTrials.gov ↗ · Coronary Artery Disease, Diabete Type 2	Not applicable	Not yet open	2025-07	China
Etiological Classification-guided Individual Intervention in Primary Hypertension NCT06941935 · ClinicalTrials.gov ↗ · Hypertension	Not applicable	Not yet open	2025-06	China
Reinforced Versus Conventional Anastomosis in Laparoscopic Low Rectal Cancer Resection: A Comparative Study NCT07346534 · ClinicalTrials.gov ↗ · Low Rectal Cancer, Rectal Neoplasms, Colorectal Cancer	Not applicable	By invitation	2022-06	China
Amino Acid (15) Peritoneal Dialysis Solution for Nutritional Improvement in Peritoneal Dialysis Patients NCT07370441 · ClinicalTrials.gov ↗ · End-stage Renal Disease (ESRD), Peritoneal Dialysis (PD), Nutritional Status Drug: Amino acid (15) peritoneal dialysis	Phase 4	By invitation	2026-05	China
D615L vs Zeiss 839MP: Visual Quality NCT07571694 · ClinicalTrials.gov ↗ · Cataract	Observational	Active, closed	2025-04	China
Clinical Safety and Efficacy of Fecal Microbiota Transplantation (FMT) in the Treatment of Alzheimer's Disease NCT06920212 · ClinicalTrials.gov ↗ · Fecal Microbiota Transplantation	Not applicable	Active, closed	2024-10	China
Exploring the Effect of Colonic J-pouch in Anorectal Preservation Surgery for Ultra-low Rectal Cancer. NCT06601985 · ClinicalTrials.gov ↗ · Rectum Cancer, Faecal Incontinence, Faecal Incontinence with Faecal Urgency	Observational	Active, closed	2022-12	China
Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study NCT07149441 · ClinicalTrials.gov ↗ · Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis), Fecal Microbiota Transplantation Drug: Infliximab	Not applicable	Active, closed	2025-08	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Shanghai 10th People's Hospital trials

8 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Infliximab2 Adalimumab1 Amino acid (15) peritoneal dialysis1 Coenzyme I1 Guselkumab1 Spermidine1 Ustekinumab1 Vedolizumab1

Conditions in Shanghai 10th People's Hospital trials

47 conditions

Hypertension3 Atrial Fibrillation2 Hyperlipidemia2 Heart Failure2Fecal Microbiota Transplantation2Acute Myocardial Infarction2 Cataract1High-risk Patients With Pancreatic Exocrine Insufficiency1Enteral Nutrition Feeding1Vascular Aging1NAD1Polycystic Ovary Syndrome1Acute Myocardial Infarction (AMI)1Periodontal Disease1GBM1Cardiovascular Diseases1Cardiovascular Morbidity1Subclinical Organ Damage1Digital Health1Lung Cancer1Renal Denervation Therapy1Obesity & Overweight1Perioperative Neurocognitive Disorder1Crohn's Disease (CD)1

By trial register

Register	Trials	Recruiting
Clinical trials in China	30	14

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Hypertension

Sponsor	Trials
ReCor Medical	6
Medtronic Vascular	5
Peking University	5
China National Center for Cardiovascular Diseases	5
Shanghai Jiao Tong University School of Medicine	3
Beijing Friendship Hospital	3
Jing Liu	3
Aktiia	2
First Hospital of China Medical University	2
Qifu Li	2

Sponsors with the most current trials registered for this condition.

Questions about Shanghai 10th People's Hospital trials

How many clinical trials does Shanghai 10th People's Hospital sponsor?

Shanghai 10th People's Hospital is the lead sponsor of 30 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Shanghai 10th People's Hospital trials recruiting?

Yes. 14 of its 30 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Shanghai 10th People's Hospital testing?

Its current trials name 8 drugs and biologicals as interventions. The most frequent are Infliximab (2), Adalimumab (1), Amino acid (15) peritoneal dialysis (1), Coenzyme I (1) and Guselkumab (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Shanghai 10th People's Hospital clinical trials